Lyophilized Peptide Tb500 (Thymosin Beta) with 99% Purity 2mg/Vial 5mg/Vial

Details:

Tranexamic acid
Tranexamic acid CAS: 701-54-2
Tranexamic acid MF: C8H15NO2
Tranexamic acid MW: 157.21
Tranexamic acid EINECS: 214-818-2
Tranexamic acid mp 233 ° C
Tranexamic acid storage temp. Refrigerator
Tranexamic acid Appearance White Solid
Tranexamic acid Chemical Name: Trans-4-(aminomethyl)cyclohexanecarboxylic acid

Tranexamic acid is given to stop or reduce heavy bleeding. In some medical conditions, the body breaks down blood clots too fast, not allowing the bleeding to stop and the wound to heal. Tranexamic acid works by blocking the breakdown of clots in the body.
How does Tranexamic Acid work? What will it do for me?
Tranexamic acid belongs to the class of medications called antifibrinolytic agents. This medication is used to prevent or reduce bleeding in certain conditions, such as dental surgery, heavy menstrual bleeding, nose bleeds and bleeding inside the eye.
Why is this medication prescribed?
Tranexamic acid is used to treat heavy bleeding during the menstrual cycle (monthly periods) in women. Tranexamic acid is in a class of medications called antifibrinolytics. It works to improve blood clotting.
Tranexamic acid is an antifibrinolytic. It works by preventing blood clots from breaking down too quickly. This helps to reduce excessive bleeding.
Medical uses
Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular and large orthopedic procedures. Its oral form is now being evaluated for use in outpatient conditions involving heavy bleeding.
Trauma
Tranexamic acid has been found to decrease the risk of death in people who have significant bleeding due to trauma. However, it may actually increase the risk of death due to bleeding if administered more than 3 hours after the injury.
Heart surgery
Tranexamic acid is commonly used in cardiac surgery, both with and without cardiopulmonary bypass. It replaces aprotinin.
Orthopedic surgery
Tranexamic acid is used in orthopedic surgery to reduce blood loss, to the extent of reducing or altogether abolishing the need for perioperative blood collection. It is of proven value in clearing the field of surgery and reducing pre- and postoperative blood loss. Drain and number of transfusions are reduced. However, the hidden blood loss is not reduced. Still, it is becoming an important tool in the anaesthetist's arsenal. It is commonly used in joint replacement surgery.
Craniofacial surgery
Use of tranexamic acid in surgical corrections of craniosynostosis in children reduces the need for blood transfusions.
Menstrual bleeding
Used as firstline nonhormonal treatment of dysfunctional uterine bleeding, and heavy bleeding associated with uterine fibroids. An August 2007 study showed patients treated with tranexamic acid are more likely to develop thrombosis and necrosis in their fibroids, and may result in pain and fever. The histological appearance of the necrosis in women treated by tranexamic acid is no different from the spontaneous incidence of thrombosis. The U. S. Food and Drug Administration (FDA) approved tranexamic acid oral tablets (brand name Lysteda) for treatment of heavy menstrual bleeding on 13 November 2009.
Dentistry
Tranexamic acid is used in dentistry in the form of a 5% mouth rinse after extractions or surgery in patients with prolonged bleeding time, e. G. From acquired or inherited disorders.
Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.
Brand names
Tranexamic acid is marketed in the U. S. And Australia in tablet form as Lysteda and in IV form as Cyklokapron and Transamin, in the UK as Cyclo-F and Femstrual, in Asia as Transcam, in Bangladesh as Traxyl, in South America as Espercil, in Japan as Nicolda, in France and Romania as Exacyl and in Egypt as Kapron. In the Philippines, its capsule form is marketed as Hemostan...